| Loretta Joyce Stump, | |
|
Rr 1 Box 67, Harlem, MT 59526-9705 | |
| (406) 673-3849 | |
| (406) 673-3214 |
| Full Name | Loretta Joyce Stump |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Community Health |
| Location | Rr 1 Box 67, Harlem, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124233275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC1500X | Registered Nurse - Community Health | 13340 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Loretta Joyce Stump, Po Box 1288, Harlem, MT 59526-1288 Ph: (406) 673-3849 | Loretta Joyce Stump, Rr 1 Box 67, Harlem, MT 59526-9705 Ph: (406) 673-3849 |
News Archive
A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce seizures in patients with tuberous sclerosis complex - a genetic disease characterized by benign tumors on multiple organ systems.
In its first year, an innovative virtual program has substantially increased mistreated elderly Texans' access to elder mistreatment and geriatric experts with The University of Texas Health Science Center at Houston
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, was granted Fast Track designation by the U.S. Food and Drug Administration for perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of refractory advanced colorectal cancer.
The Sunnyvale, Calif.-based company Cepheid on Tuesday announced it has developed a rapid diagnostic test for tuberculosis that it will sell at a reduced cost in developing countries, the San Francisco Chronicle reports. The test was developed in partnership with the Foundation for Innovative New Diagnostics, the University of Medicine and Dentistry of New Jersey, and the National Institute of Allergy and Infectious Diseases.
Mary Rockland was in a panic when she learned that she was diagnosed with invasive breast cancer. Like many patients, she trusted her doctor when he told her that a lump in her breast was cancerous, and relied on his judgment when he recommended a bilateral mastectomy.
› Verified 3 days ago
Audrey Flansburg, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 656 Agency Main St, Harlem, MT 59526 Phone: 406-353-3219 Fax: 406-353-3283 | |
Barbara A Haubrich, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Rr 1 Box 67, Harlem, MT 59526 Phone: 406-353-3100 | |
Sandy Filesteel, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 669 Agency Main St, Harlem, MT 59526 Phone: 406-353-3100 | |
Kathleen M Olver, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Rr 1 Box 67, Harlem, MT 59526 Phone: 406-353-3100 Fax: 406-353-3229 | |
Kathleen Adams, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Rr 1 Box 67, Harlem, MT 59526 Phone: 406-673-3777 Fax: 406-673-3144 | |
Monte A Healy, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 456 Grosventre Ave, Harlem, MT 59526 Phone: 406-353-3282 Fax: 406-353-3283 |